A. Attaran, D. Barry, S. Basheer, R. Bate, D. Benton et al., How to achieve international action on falsified and substandard medicines, BMJ, vol.345, issue.nov13 22, p.7381, 2011.
DOI : 10.1136/bmj.e7381

A. Delepierre, A. Gayot, A. Carpentier, R. Bartlein, A. Dodoo et al., Medline: 22621827] 5. World Health Organization. Counterfeit and substandard drugs in Myanmar and Viet Nam: Report of a study carried out in cooperation with the Governments of Myanmar and Viet Nam URL: http://apps.who.int/medicinedocs/pdf/s2276e/ s2276e A situational analysis of pharmacovigilance plans in the Global Fund Malaria and US President's Malaria Initiative proposals, al. Pharmacovigilance and new essential drugs in Africa: Zambia draws lessons from its own experiences and beyond, pp.247-255148184, 1999.

M. Letourneau, G. Wells, W. Walop, and P. Duclos, Improving Global Monitoring of Vaccine Safety, Drug Safety, vol.26, issue.5, pp.389-398, 2008.
DOI : 10.2165/00002018-200831050-00003

A. Bentsi-enchill, I. Zongo, S. Khamassi, R. Pless, R. Thombiano et al., Monitoring of adverse events during the 2003 mass vaccination campaign with a trivalent meningococcal A/C/W135 polysaccharide vaccine in Burkina Faso, Vaccine, vol.25, issue.1, p.17544552, 2007.
DOI : 10.1016/j.vaccine.2007.04.045

A. Kraigher and V. Ucakar, Surveillance of adverse events following immunization against pandemic influenza in Slovenia in season, Vaccine, vol.1028, issue.33, pp.5467-5472, 2009.

M. Pirmohamed, K. Atuah, A. Dodoo, and P. Winstanley, Pharmacovigilance in developing countries, BMJ, vol.335, issue.7618, p.462, 2007.
DOI : 10.1136/bmj.39323.586123.BE

I. Edwards, The WHO World Alliance for Patient Safety, Drug Safety, vol.39, issue.3, pp.379-386, 2005.
DOI : 10.2165/00002018-200528050-00002

R. Fernandopulle and K. Weerasuriya, What Can Consumer Adverse Drug Reaction Reporting Add to Existing Health Professional-Based Systems?, Drug Safety, vol.328, issue.4, pp.219-225, 2003.
DOI : 10.2165/00002018-200326040-00002

R. Gaur, Cellular Network Based Drug Monitoring, Asia Pacific Journal of Public Health, vol.42, issue.6, pp.1025-1026, 2011.
DOI : 10.1177/1010539511422741

W. Curioso, B. Karras, P. Campos, C. Buendia, K. Holmes et al., Design and implementation of Cell-PREVEN: a real-time surveillance system for adverse events using cell phones in Peru, AMIA Annu Symp Proc, pp.176-180, 2005.

. Globalhealthhub and . Org, Data Collected via FrontlineSMS is used by Ministry of Agriculture in Cambodia URL: http://www.globalhealthhub.orgdata-collected-via-frontlinesms-is-used-by-ministry-of-agriculture-in, 2012.

. Frontlinesms, Malaria Diagnosis in Real-Time via SMS URL: http://www.frontlinesms.com malaria-diagnosis-in-real-time-via-sms, 2011.

R. Menzies, D. Mahajan, M. Gold, I. Roomiani, P. Mcintyre et al., Annual report: surveillance of adverse events following immunisation in Australia, Commun Dis Intell Q Rep, vol.33, issue.4, pp.365-381, 2008.

A. Avery, C. Anderson, C. Bond, H. Fortnum, A. Gifford et al., Evaluation of patient reporting of adverse drug reactions to the UK ???Yellow Card Scheme???: literature review, descriptive and qualitative analyses, and questionnaire surveys, Health Technology Assessment, vol.15, issue.20, pp.1-234, 2011.
DOI : 10.3310/hta15200

S. Baron, F. Goutard, K. Nguon, and A. Tarantola, Use of a Text Message-Based Pharmacovigilance Tool in Cambodia: Pilot Study, Journal of Medical Internet Research, vol.15, issue.4, p.68, 2013.
DOI : 10.2196/jmir.2477
URL : https://hal.archives-ouvertes.fr/pasteur-00815571

F. ©sophie-baron, K. Goutard, A. Nguon, and . Tarantola, Originally published in the Journal of This is an open-access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, Medical Internet Research